← Back to Search

Procedure

Treatment for Neuropathic Pain

N/A
Recruiting
Led By Timothy Deer, MD
Research Sponsored by Saint Francis Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be willing and capable of giving informed consent
Be 18 years of age or older at the time of enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights

Study Summary

This trial is collecting information to see how well a specific therapy called CL-SCS works for real patients dealing with chronic pain.

Who is the study for?
This trial is for adults over 18 with chronic, intractable pain of the trunk or limbs that hasn't improved after at least 6 months of treatment. Participants must have a high level of baseline pain and be able to follow study procedures. Pregnant or nursing individuals, those with certain medical conditions, psychological disorders, other active implantable devices, prior SCS experience, or who are in another clinical study cannot join.Check my eligibility
What is being tested?
The ULTRA trial is observing how well Evoke Closed-loop Spinal Cord Stimulation (CL-SCS) therapy works on people with chronic pain in real-world settings. It's not testing against another treatment but looking at patient outcomes after receiving this specific intervention.See study design
What are the potential side effects?
While the side effects aren't specified here since it's an observational study of real-world use, typical SCS-related side effects can include infection risk at the implant site, discomfort or problems due to device presence like tingling sensations from nerve stimulation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing and able to agree to participate in the study.
Select...
I am 18 years old or older.
Select...
I have had severe, ongoing pain in my body for over 6 months that hasn't improved with treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
VAS - Visual Analog Scale
Secondary outcome measures
PROMIS-29

Find a Location

Who is running the clinical trial?

Saint Francis HospitalLead Sponsor
2 Previous Clinical Trials
30 Total Patients Enrolled
Saluda Medical Americas, Inc.Industry Sponsor
1 Previous Clinical Trials
134 Total Patients Enrolled
Timothy Deer, MDPrincipal InvestigatorSpine and Nerve Center of Saint Francis Hospital
1 Previous Clinical Trials
173 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of participants being selected for enrollment in this clinical trial?

"Indeed, as per clinicaltrials.gov data, this research is presently enrolling volunteers. The trial was initially shared on January 30th, 2024 and the latest revision took place on February 6th of the same year. The study aims to recruit a total of 25 participants from one designated site."

Answered by AI

Are there any available vacancies for participants in this clinical trial?

"Indeed, information from clinicaltrials.gov reveals that this investigation is actively seeking suitable participants. The trial was initially listed on the 30th of January, 2024 and its most recent update was made on the 6th of February, 2024. There is a requirement for 25 patients to be recruited at a single designated site."

Answered by AI
~17 spots leftby Jan 2026